The ANTXR2 gene helps cells attach to and organize the supportive material around them, especially in the skin, joints, and gut. This gene plays an important role in how your body maintains healthy connective tissue. If both copies carry a harmful variant, material can build up in tissues and lead to painful skin bumps, thickened skin, stiff joints, gum overgrowth, and sometimes bowel problems. These changes are linked to hyaline fibromatosis spectrum disorder, a rare inherited condition with symptoms that can range from milder skin and joint changes to more widespread illness.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, the cell components that do the work. Other genes mainly direct when certain processes happen, where they occur, and how active they are. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
ANTXR2Gene function
What if the gene works
The ANTXR2 gene helps cells attach to surrounding support tissue and maintain connective tissue. This supports normal skin, gut, joints, and blood vessel structure.
Risk
What if the gene does not work
Pathogenic variants in the ANTXR2 gene cause hyaline fibromatosis syndrome, which can range from milder skin lumps and joint stiffness to earlier, more widespread disease with pain, diarrhea, poor growth, and organ involvement.
Treatment
What does that mean for your treatment
No treatment or drug choice guided specifically by the ANTXR2 gene is currently established. Research is exploring the ANTXR2 gene as a drug target to block anthrax toxin entry and as a possible biomarker in some cancers.
Conditions associated with ANTXR2
Gene function
What if the gene works
Your cells use the ANTXR2 gene to stay connected to the support material around them and keep tissues orderly. Although ANTXR2 is also called anthrax toxin receptor 2, its usual job in the body is helping cells attach, sense their surroundings, and manage that support mesh. This day to day work supports connective tissue throughout the body.
The ANTXR2 gene helps cells latch onto nearby support proteins in the tissue around them. This gives cells a steady foothold and helps keep layers of tissue organized.
ANTXR2 also helps control the support mesh outside cells, called the extracellular matrix (the material that holds tissues together). This helps the body balance building, holding, and clearing that material so tissues stay well structured.
Its protein sits at the cell surface and acts like a docking point for certain outside proteins. After binding, it can help move some material into the cell, which supports normal cell responses and routine cleanup.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help explain normal differences among people, such as appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ANTXR2 gene can change the protein’s shape, stability, or delivery to the cell surface, so cells make less working protein or none at all. Milder variants may leave some activity, while more severe variants can stop protein production or sharply disrupt how the protein interacts with material around the cell. In hyaline fibromatosis syndrome, this range in ANTXR2 gene variant effects often tracks with how early features appear and how extensive they become.
How variants are linked to conditions
Pathogenic variants in the ANTXR2 gene cause hyaline fibromatosis syndrome. This rare inherited condition can lead to firm skin lumps, thickened skin, joint stiffness, gum overgrowth, poor growth, and in some people bowel symptoms. Older names for parts of this spectrum were juvenile hyaline fibromatosis and infantile systemic hyalinosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ANTXR2, the main thing that changes risk is inheritance: these health problems usually happen only when a child inherits a changed copy of the ANTXR2 gene from both parents. Risk is higher in families with a known ANTXR2 change and when parents are related by blood, such as cousins.
Inheritance of ANTXR2 variants
For ANTXR2 gene inheritance, the well-established pattern is autosomal recessive. This means a person usually develops an ANTXR2-related condition only when they inherit two disease-causing variants in the ANTXR2 gene, one from each parent. Parents who each carry one variant are typically unaffected carriers. With each pregnancy, two carrier parents have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial ANTXR2 variant.
What does my ANTXR2 result mean for my family?
For families with an ANTXR2-related condition, relatives may also be carriers even if they have no symptoms. Brothers and sisters of an affected child may also be affected or may carry the same gene change, and other close relatives may want to learn whether the change runs in the family. This pattern is usually recessive, so the main family question is often carrier status rather than symptoms in every generation.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the ANTXR2 gene, ANTXR2 genetic testing analyzes DNA from a blood sample, saliva, or a cheek swab. A lab checks the gene’s spelling and compares it with the usual pattern to identify variants that may help confirm or rule out an inherited condition.
When should I consider getting a genetic test?
Consider genetic testing for the ANTXR2 gene if a child has signs of hyaline fibromatosis syndrome, such as painful skin lumps, stiff joints, severe gum overgrowth, or early diarrhea and poor growth. Testing can also help when this condition runs in the family or both parents are known carriers.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the specific type of variant. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put a person’s experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person but less well for another, or why some people are more sensitive to side effects. These differences are common and are one part of why treatment response varies from person to person.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect response to medications. It looks at the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This understanding can support more informed and more individualized treatment decisions. To explore this subject in greater detail, more information is available in the LearnHub.
Drugs influenced by the ANTXR2 gene
When should I seek medical advice?
There is not yet strong evidence that this gene can reliably guide how medicines are chosen or used, so any concerns about treatment, side effects, or new symptoms are best discussed with your doctor.
History
ANTXR2 first drew major scientific attention in the early 2000s when researchers identified it as a receptor used by anthrax toxin, which led to the alternate name CMG2. Soon after, variants in the ANTXR2 gene were linked to rare inherited conditions once described separately as juvenile hyaline fibromatosis and infantile systemic hyalinosis. Scientific classifications changed as researchers learned more about the gene. Those two conditions were later understood to be part of one spectrum, now called hyaline fibromatosis syndrome. This work helped connect a striking set of skin, joint, and tissue changes with a single genetic cause. From these first observations, research expanded steadily and made ANTXR2 an important gene in both rare disease genetics and infectious disease research.